Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Care without a compass: Including patients with cancer in COVID-19 studies
Christopher R. Friese, Toni K. Choueiri, Narjust Duma, et al.
Cancer Cell (2021) Vol. 39, Iss. 7, pp. 895-896
Open Access | Times Cited: 16

Showing 16 citing articles:

Seroconversion rates following COVID-19 vaccination among patients with cancer
Astha Thakkar, Jesus D. Gonzalez‐Lugo, Niyati Goradia, et al.
Cancer Cell (2021) Vol. 39, Iss. 8, pp. 1081-1090.e2
Open Access | Times Cited: 341
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
Alfredo Addeo, Pankil Shah, Natacha Bordry, et al.
Cancer Cell (2021) Vol. 39, Iss. 8, pp. 1091-1098.e2
Open Access | Times Cited: 227
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
Arielle Elkrief, Julie Wu, Chinmay Jani, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 303-330
Open Access | Times Cited: 35
SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies
Bin Ni, Ahmad Yanis, Kevin Dee, et al.
Blood Reviews (2022) Vol. 56, pp. 100984-100984
Open Access | Times Cited: 12
The antibody response of haematological malignancies to COVID-19 infection and vaccination
Nicole A. Seebacher
British Journal of Cancer (2022) Vol. 126, Iss. 5, pp. 691-692
Open Access | Times Cited: 11
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination
Miriam Echaide, Ibone Labiano, Marina Delgado, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4464-4464
Open Access | Times Cited: 11
Outpatient anti-spike monoclonal antibody administration is associated with decreased morbidity and mortality among patients with cancer and COVID-19
Panos Arvanitis, Alexis Hope Lerner, Kendra Vieira, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 6, pp. 2739-2748
Open Access | Times Cited: 5
Organisation of cancer care in troubling times: A scoping review of expert guidelines and their implementation during the COVID-19 pandemic
Brenda Bogaert, Victoria Buisson, Zisis Kozlakidis, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 173, pp. 103656-103656
Open Access | Times Cited: 7
The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study
Dat Ngo, Jason Chen, Jose Tinajero, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 3
COVID-19 vaccination in patients with cancer, a rapid review
Laudy Chehade, Jad Zeitoun, Dorothy Lombe, et al.
ecancermedicalscience (2022) Vol. 16
Open Access | Times Cited: 4
Dosing Schedule Modification of COVID-19 Vaccine in Immunosuppressed and Cancer Patient: A Review of Current Suggestions
Mohd Turzo Rahman, Homayra Rahman, Ashrak Shad
(2023)
Open Access | Times Cited: 1
The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study
Cecilia A. Castellano, Tianyi Sun, Deepak Ravindranathan, et al.
Cancer (2024) Vol. 130, Iss. 12, pp. 2191-2204
Closed Access
Outpatient anti-spike monoclonal antibody administration is associated with decreased morbidity and mortality among patients with cancer and COVID-19
Panos Arvanitis, Alexis Hope Lerner, Kendra Vieira, et al.
Research Square (Research Square) (2023)
Open Access
IMMUNE PROFILING UNCOVERS POTENT ADJUVANT CAPACITIES OF SARS-COV-2 INFECTION TO VACCINATION LEADING TO MEMORY T CELL RESPONSES WITH A TH17 SIGNATURE IN CANCER PATIENTS
Miriam Echaide, Ibone Labiano, Marina Delgado, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
COVID-19 Vaccine Among Actively-Treated People With Cancer: A Glimpse Into the Known Unknowns?
Astha Thakkar, Sanjay Mishra, Jeremy L. Warner
JNCI Journal of the National Cancer Institute (2021) Vol. 114, Iss. 2, pp. 169-171
Open Access
Cancer Patients Have Necessary Been COVID-19 Vaccinated
Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn, Porntep Siriwanarangsun
Trends in Internal Medicine (2021) Vol. 1, Iss. 1
Open Access
Page 1

Scroll to top